Correlation Between the 18F-FDG Uptake Assessed by PET/CT and Pathological Data in Well-Differentiated Digestive Neuroendocrine Tumors

被引：0
|
作者：
Bucau, Margot
Laurent-Bellue, Astrid
Cros, Jerome
Hentic-Dhome, Olivia
Bedossa, Pierre
Ruszniewski, Philippe
Lebtahi, Rachida
Couvelard, Anne
机构：
来源：
GASTROENTEROLOGY | 2015年 / 148卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1918
引用
收藏
页码：S935 / S935
页数：1
相关论文
共 50 条
  • [1] Correlation between the 18F-FDG Uptake and Pathological Data in Well-Differentiated Digestive and Pulmonary Neuroendocrine Tumors (NET)
    Bucau, M.
    Laurent-Bellue, A.
    Cros, J.
    Hentic, O.
    Rebours, V.
    Bedossa, P.
    Ruszniewski, P.
    Lebtahi, R.
    Couvelard, A.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 101 - 101
  • [2] Biological Correlation of 18F-FDG Uptake on PET in Pulmonary Neuroendocrine Tumors
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Ohde, Yasuhisa
    Naito, Tateaki
    Kondo, Haruhiko
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    Takahashi, Toshiaki
    ANTICANCER RESEARCH, 2013, 33 (10) : 4219 - 4228
  • [3] Overall Survival of Well-Differentiated Neuroendocrine Tumors Evaluated by F-18-FDG-PET
    Binderup, T.
    Knigge, U.
    Federspiel, B.
    Hansen, Palnaes C.
    Loft, A.
    Kjaer, A.
    NEUROENDOCRINOLOGY, 2012, 96 : 21 - 21
  • [4] Dual Somatostatin Receptor/18F-FDG PET/CT Imaging in Patients with Well-Differentiated, Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors
    Metser, Ur
    Nunez, Jose E.
    Chan, David
    Kulanthaivelu, Roshini
    Murad, Vanessa
    Santiago, Anna T.
    Singh, Simron
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (10) : 1591 - 1596
  • [5] Clinical usefulness of FDG-PET for management of well-differentiated digestive neuroendocrine tumors
    Perrier, Marine
    Hentic, Olivia
    Walter, Thomas
    Cao, Christine Do
    Cadiot, Guillaume
    de Mestier, Louis
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (12) : 1521 - 1524
  • [6] 18F-FDG Uptake in Well-Differentiated Neuroendocrine Tumors Correlates with Both Ki-67 and VHL Pathway Inactivation
    Bucau, Margot
    Laurent-Bellue, Astrid
    Pote, Nicolas
    Hentic, Olivia
    Cros, Jerome
    Mikail, Nidaa
    Rebours, Vinciane
    Ruszniewski, Philippe
    Lebtahi, Rachida
    Couvelard, Anne
    NEUROENDOCRINOLOGY, 2018, 106 (03) : 274 - 282
  • [7] Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor
    Sharma, Punit
    Naswa, Niraj
    Suman, Sudhir K. C.
    Alvarado, Luis Andres
    Dwivedi, Alok Kumar
    Yadav, Yashwant
    Kumar, Rakesh
    Ammini, Ariachery C.
    Bal, Chandrasekhar
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (12) : 2194 - 2202
  • [8] 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT Findings in a Patient With Primary Renal Well-Differentiated Neuroendocrine Tumor
    Sahin, Rahime
    Baykal Koca, Sevim
    Yucetas, Ugur
    Cermik, Tevfik Fikret
    Ergul, Nurhan
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (07) : E503 - E505
  • [9] Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor
    Punit Sharma
    Niraj Naswa
    Sudhir Suman KC
    Luis Andres Alvarado
    Alok Kumar Dwivedi
    Yashwant Yadav
    Rakesh Kumar
    Ariachery C. Ammini
    Chandrasekhar Bal
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 2194 - 2202
  • [10] 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer
    Shammas, Amer
    Degirmenci, Berna
    Mountz, James M.
    McCook, Barry M.
    Branstetter, Barton
    Bencherif, Badreddine B.
    Joyce, Judith M.
    Carty, Sally E.
    Kuffner, Haruko A.
    Avril, Norbert
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (02) : 221 - 226
12345